11/14
04:53 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
11/10
08:02 am
avbp
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
Low
Report
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
11/10
08:00 am
avbp
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
Low
Report
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
11/5
11:27 am
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: FMR LLC
10/30
02:04 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
10/17
06:06 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
10/15
04:07 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
Medium
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
9/9
08:00 am
avbp
Form 8-K ArriVent BioPharma, Inc. For: Sep 09
Low
Report
Form 8-K ArriVent BioPharma, Inc. For: Sep 09